Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 2/2001

01-02-2001 | Original Article

Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans

Authors: L. Gianotti, J. Ramunni, F. Lanfranco, B. Maccagno, R. Giordano, F. Broglio, M. Maccario, E. E. Muller, E. Ghigo, Dr. E. Arvat

Published in: Journal of Endocrinological Investigation | Issue 2/2001

Login to get access
Metadata
Title
Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans
Authors
L. Gianotti
J. Ramunni
F. Lanfranco
B. Maccagno
R. Giordano
F. Broglio
M. Maccario
E. E. Muller
E. Ghigo
Dr. E. Arvat
Publication date
01-02-2001
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 2/2001
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/BF03343815

Other articles of this Issue 2/2001

Journal of Endocrinological Investigation 2/2001 Go to the issue

Rapid Communication

CDY 1 analysis in infertile patients with DAZ deletions

Case Report

Non-secreting atypical parathyroid adenoma

Letter to The Editor

Reply from: M. Giusti

Original Article

Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases

Case Report

Extensive sterile abscess in an invasive fibrous thyroiditis (Riedel’s thyroiditis) caused by an occlusive vasculitis

Case Report

Peritoneal dialysis in an infant with Type 1 diabetes and hyperosmolar coma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits